Form 4 for MEDP Medpace Holdings, Inc.

Accepted 2021-07-20 00:00:00 ET · period of report 2021-07-16 · accession 0001567619-21-013713 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2021-07-20	2021-07-16+	MEDP	Medpace Investors, LLC	10%	S - Sale	$182.65	-13.9K	6.14M	-0.2%	-$2.54M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-07-16	S	D	12,454	$182.83	6,138,961	D	—	—	(F1) The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. (F2) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.605 to $184.48. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
2	Common	Common Stock	2021-07-19	S	D	1,442	$181.11	6,137,519	D	—	—	(F1) The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. (F3) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $182.235. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.